Vista Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter/half year ended September 30, 2016.
The above information is a part of company’s filings submitted to BSE.